GlassScriptPhysician profile
Daniel Richard Berg
NPI 1659362069
$245.48
in general payments reported to CMS, 2019-2025
11 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.33 · 2020: $27.49 · 2023: $35.41 · 2024: $18.63 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $50.43 | 2025 | Nexletol |
| Amgen INC. | $38.90 | 2025 | Otezla, Repatha |
| Exact Sciences Corporation | $37.37 | 2023-2024 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $27.49 | 2020 | |
| Dexcom, INC. | $16.67 | 2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $14.29 | 2025 | Minimed 780g |
| Gilead Sciences, INC. | $13.29 | 2019 | |
| Genentech USA, INC. | $13.10 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.59 | 2019 | |
| Novo Nordisk INC | $11.36 | 2019 | |
| Mylan Specialty L.P. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.